Epigral Enterprise Value (EV)

Epigral Ltd Enterprise Value

The Epigral Ltd Enterprise Value is a key financial metric used by investors to evaluate Epigral Ltd's valuation, profitability, and overall financial performance. Tracking the Epigral Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Epigral Ltd (NSE: EPIGRAL, BSE: 543332) is currently trading at ₹810.45, with a market capitalization of ₹34.93B. As a leading company in the Process industries sector and Chemicals: agricultural industry, monitoring the Epigral Ltd Enterprise Value is essential for fundamental analysis.

Epigral Ltd Enterprise Value Current Value

The current Epigral Ltd Enterprise Value stands at 85.13B.

The latest Epigral Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Epigral Ltd Enterprise Value Historical Trend

The Epigral Ltd Enterprise Value has shown the following historical trend:

• 2024: 85.13B
• 2023: 55.11B
• 2022: 47.83B
• 2021: 50.14B
• 2020: 0

The recent rise in Epigral Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.

What Epigral Ltd Enterprise Value Indicates for Investors

The Epigral Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Epigral Ltd.

Epigral Ltd Enterprise Value Analysis Summary

The Epigral Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Epigral Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Epigral Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.